Navigation Links
Savient Pharmaceuticals Submits European Marketing Authorization Application for KRYSTEXXA®
Date:5/4/2011

edically appropriate dose or for whom these drugs are contraindicated. KRYSTEXXA is not recommended for the treatment of an elevation of blood concentration of uric acid that is not accompanied by signs or symptoms of gout, a condition referred to as asymptomatic hyperuricemia.

ABOUT SAVIENT PHARMACEUTICALS, INC.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP"). Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA.  Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S. For more information, please visit the Company's website at www.savient.com.

FORWARD-LOOKING STATEMENTS

All statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions identify forward-looking stateme
'/>"/>

SOURCE Savient Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
2. Savient Pharmaceuticals to Present Multiple Abstracts at The European League Against Rheumatism (EULAR) 2011 Annual Congress
3. Savient Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
4. Savient Pharmaceuticals to Hold First Quarter 2011 Financial Results
5. Savient Pharmaceuticals to Present at the ROTH 23rd Annual OC Growth Stock Conference
6. Savient Pharmaceuticals to Present at the 31st Annual Cowen & Co. Health Care Conference
7. Savient Pharmaceuticals Announces U.S. Launch of KRYSTEXXA™; Reports Fourth Quarter and Year-End 2010 Financial Results
8. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2010 Results Conference Call on Friday, February 25, 2011
9. Savient Closes Sale of $230 Million in Convertible Senior Notes
10. Savient Announces Proposed Offering of $125 Million in Convertible Senior Notes
11. Savient Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014  When it comes to welcoming our ... ready to roll out the red carpet. Healthcare ... of HAL 9000-like robots into our human sphere. With healthcare ... a pressing need to apply new technologies to help with ... for medical robotics is expected to increase from $1.7 billion ...
(Date:7/23/2014)... , July 23, 2014 Research ... "Disposable Medical Gloves (Exam and Surgical) Markets Worldwide ... http://photos.prnewswire.com/prnh/20130307/600769 The purpose of ... market for Disposable Medical (Exam and Surgical) Gloves. The ... market for these products. Topics covered include ...
(Date:7/23/2014)... July 23, 2014  Lightlake Therapeutics Inc. ("Lightlake") ... based on its expertise in opioid antagonists, announced ... drug application ("IND") with respect to its naloxone-based ... today that it has received an additional commitment ... part of the National Institutes of Health ("NIH"), ...
Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3
... -- American Oriental Bioengineering, Inc. (NYSE: ... company dedicated to improving healthcare through the development, ... prescription and over-the-counter ("OTC") products, today announced the ... ("AWRO Liquid"), an OTC herbal supplement aimed at ...
... Wash., Nov. 11, 2010 Applied Precision, a leader in ... of four of its revolutionary DeltaVisio n ... eight weeks. The Delta V ... more than doubles the optical resolution of the traditional light ...
Cached Medicine Technology:American Oriental Bioengineering Introduces Wujia Rongxue Oral Liquid 2Applied Precision Installs a Record Four New DeltaVision OMX Super-Resolution Imaging Systems in Eight Weeks 2
(Date:7/23/2014)... the secrets to better treating the pernicious disorders of ... a paper from American University,s Center for Behavioral Neuroscience. ... obesity with therapies aimed at areas of the brain ... on the hippocampus could play a role in reducing ... therapies and preventive measures often fall short. This is ...
(Date:7/23/2014)... Kathleen Doheny ... News) -- Weight-loss surgery appears to have an additional ... in women, according to a new study. The ... weight-loss surgery program reported having incontinence prior to the ... urinary symptoms either improved or disappeared, said study researcher ...
(Date:7/23/2014)... effort to catalog the molecular causes of stomach ... have identified four subtypes of tumors based on ... the new classification promises to advance clinical research ... killer worldwide. , In a report in ... Research Network said they analyzed 295 samples of ...
(Date:7/23/2014)... 23, 2014 Ticket Down is ... United tickets at Michigan Stadium . One of the ... will be held at the Big House in Ann Arbor. ... will be home to a game between Manchester United from ... The game will be held on August 2nd and could ...
(Date:7/23/2014)... 2014 Ticket Down is reliable ... in Dallas, TX at the Cotton Bowl. The 2014 ... in the United States and Canada beginning on July 24. ... from La Liga, Serie A, English Premier League, and Superleague ... Manchester City, Olympiacos, Inter Milan, Liverpool, AS Roma, and Real ...
Breaking Medicine News(10 mins):Health News:Targeting the brain to treat obesity 2Health News:Targeting the brain to treat obesity 3Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 2Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 3Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3Health News:Real Madrid vs. Manchester United Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for ManU vs. Real Madrid Guinness International Champions Cup Tickets 2Health News:Real Madrid vs. Manchester United Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for ManU vs. Real Madrid Guinness International Champions Cup Tickets 3Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 3
... According to a new study shows that people with a ... to have a stroke. Previous research has suggested that reduced ... death from stroke. //The focus on potassium is, perhaps, a ... keeping sodium or salt intake low to avoid stroke. But ...
... everyone's fetish in day to day life. Keeping fit costs ... you belong to a gym or health club,// you'll be ... stairmasters. , These items typically cost thousands of dollars ... on your own. But you can get the same results ...
... is released into the blood after a meal, restrain the ... treating obesity. The reason for feeling full after a meal, ... acts on the brain to produce a feeling of satiety. ... human trial of PYY3-36. ,10 healthy volunteers received ...
... new techniques with lasers help remove lines and wrinkled ... when you're younger can take its toll in later ... on the skin. But, says Dr Arielle Kauvar, a ... readily achieve a smoother, firmer appearance. ,These ...
... be saved each year, if only everyone over the age ... Dr. Gregory Poland fe that universal vaccination in three regions// ... 40 to 50 per cent. Clearly vaccination can be a ... cent. ,Dr Poland proposes some changes to make ...
... hand spasticity among stroke survivors. Spasticity in the limbs is ... disability,// because it interferes with activities like getting dressed and ... substance that relieves muscle tightness - may help with this ... toxin (also known as botox) in stroke, a group of ...
Cached Medicine News:
... a variety of colors and classic ... styles designed with elegant jewel detail. ... women that are made from the ... in our fine timepieces, Timex branded ...
... The stylish Thalia eyeglasses eyewear ... sex appeal of the renowned ... line of eyeglasses eyewear is ... in ophthalmic styles that include ...
... Wang Eyewear, a dainty, feminine collection of ... in the UK by The Norville Group. ... curves of Vera Wang Eyewear bring metals, ... quality materials such as stainless steel, beta-titanium ...
... that almost all retailers must address these ... VALUE - not just in price but ... shows that National is among the LEADING ... offers an exciting collection of contemporary and ...
Medicine Products: